Zeroing in on Therapies at the California Stem Cell Agency
BURLINGAME, Ca. -- Directors of the California stem cell agency today mulled over a recommendation that they focus intensely on a handful of research projects that are most likely to result in commercializing a stem cell therapy.
No decisions were made, but directors raised questions about whether such a move would mean a reduction of funding for other r…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.